The Introduction of Generic Risperidone in Medicare Part D

OBJECTIVES: The introduction of generic second-generation antipsychotics (SGAs), starting with risperidone in July 2008, could reduce antipsychotic spending and cost-related use barriers. This study examines associations between generic risperidone use and spending and adherence after introduction a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Manag Care
Hlavní autoři: Fung, Vicki, Price, Mary, Busch, Alisa B., Landrum, Mary Beth, Fireman, Bruce, Nierenberg, Andrew A., Newhouse, Joseph P., Hsu, John
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4915110/
https://ncbi.nlm.nih.gov/pubmed/26799124
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky